185 related articles for article (PubMed ID: 32439797)
1. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk.
Zhu J; Shu X; Guo X; Liu D; Bao J; Milne RL; Giles GG; Wu C; Du M; White E; Risch HA; Malats N; Duell EJ; Goodman PJ; Li D; Bracci P; Katzke V; Neale RE; Gallinger S; Van Den Eeden SK; Arslan AA; Canzian F; Kooperberg C; Beane Freeman LE; Scelo G; Visvanathan K; Haiman CA; Le Marchand L; Yu H; Petersen GM; Stolzenberg-Solomon R; Klein AP; Cai Q; Long J; Shu XO; Zheng W; Wu L
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1501-1508. PubMed ID: 32439797
[TBL] [Abstract][Full Text] [Related]
2. Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma.
Zhu J; Wu K; Liu S; Masca A; Zhong H; Yang T; Ghoneim DH; Surendran P; Liu T; Yao Q; Liu T; Fahle S; Butterworth A; Alam MA; Vadgama JV; Deng Y; Deng HW; Wu C; Wu Y; Wu L
Gigascience; 2024 Jan; 13():. PubMed ID: 38608280
[TBL] [Abstract][Full Text] [Related]
3. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
4. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules.
Hu J; Jiang J; Xu B; Li Y; Wang B; He S; Ren X; Shi B; Zhang X; Zheng H; Hua B; Liu R
J Ethnopharmacol; 2024 Mar; 322():117590. PubMed ID: 38113986
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.
Sharma GG; Okada Y; Von Hoff D; Goel A
Semin Cancer Biol; 2021 Oct; 75():153-168. PubMed ID: 33049362
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
Li J; Tan W; Peng L; Zhang J; Huang X; Cui Q; Zheng J; Tan W; Wu C; Lin D
Cancer Commun (Lond); 2018 Apr; 38(1):13. PubMed ID: 29764514
[TBL] [Abstract][Full Text] [Related]
11. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.
Pistoni L; Gentiluomo M; Lu Y; López de Maturana E; Hlavac V; Vanella G; Darvasi E; Milanetto AC; Oliverius M; Vashist Y; Di Leo M; Mohelnikova-Duchonova B; Talar-Wojnarowska R; Gheorghe C; Petrone MC; Strobel O; Arcidiacono PG; Vodickova L; Szentesi A; Capurso G; Gajdán L; Malleo G; Theodoropoulos GE; Basso D; Soucek P; Brenner H; Lawlor RT; Morelli L; Ivanauskas A; ; Kauffmann EF; Macauda A; Gazouli M; Archibugi L; Nentwich M; Loveček M; Cavestro GM; Vodicka P; Landi S; Tavano F; Sperti C; Hackert T; Kupcinskas J; Pezzilli R; Andriulli A; Pollina L; Kreivenaite E; Gioffreda D; Jamroziak K; Hegyi P; Izbicki JR; Testoni SGG; Zuppardo RA; Bozzato D; Neoptolemos JP; Malats N; Canzian F; Campa D
Carcinogenesis; 2021 Aug; 42(8):1037-1045. PubMed ID: 34216462
[TBL] [Abstract][Full Text] [Related]
12. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk.
Zhong H; Liu S; Zhu J; Wu L
Int J Cancer; 2023 Jul; 153(1):103-110. PubMed ID: 36757187
[TBL] [Abstract][Full Text] [Related]
13. Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.
Jang SI; Lee HK; Chang EJ; Kim S; Kim SY; Hong IY; Kim JK; Lee HS; Yang J; Cho JH; Lee DK
Cancer Immunol Immunother; 2023 Aug; 72(8):2757-2768. PubMed ID: 37165046
[TBL] [Abstract][Full Text] [Related]
14. The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling.
Tactacan CM; Phua YW; Liu L; Zhang L; Humphrey ES; Cowley M; Pinese M; Biankin AV; Daly RJ
Mol Cancer; 2015 Jul; 14():139. PubMed ID: 26215634
[TBL] [Abstract][Full Text] [Related]
15. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk.
Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
[TBL] [Abstract][Full Text] [Related]
16. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
17. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
Giulietti M; Righetti A; Principato G; Piva F
Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
[TBL] [Abstract][Full Text] [Related]
18. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
19. The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis.
Kumar S; Santos RJ; McGuigan AJ; Singh U; Johnson P; Kunzmann AT; Turkington RC
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1090-1102. PubMed ID: 34810209
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
